Literature DB >> 32354718

Growth rate of coeliac children is compromised before the onset of the disease.

Renata Auricchio1, Pio Stellato1, Dario Bruzzese2, Donatella Cielo3, Alfredo Chiurazzi1, Martina Galatola1, Gemma Castilljeo4, Paula Crespo Escobar5, Judith Gyimesi6, Corina Hartman7, Sanja Kolacek8, Sybille Koletzko9, Ilma Korponay-Szabo6, Maria Luisa Mearin10, Caroline Meijer11, Malgoscia Pieścik-Lech11, Isabel Polanco12, Carmen Ribes-Koninckx13, Raanan Shamir14,15, Hania Szajewska16, Riccardo Troncone1, Luigi Greco1.   

Abstract

INTRODUCTION: Growth impairment has often been described in children who develop coeliac disease (CD). Based on data from the multicentre, longitudinal PreventCD study, we analysed the growth patterns of infants at genetic risk of CD, comparing those who developed CD by 6 years of age (CD 'cases', 113 infants) versus those who did not develop CD by 6 years (no CD 'controls', 831 infants).
METHODS: Weight and length/height were measured using a longitudinal protocol. Raw measurements were standardised, computing z-scores for length/height and weight; a linear mixed model was fitted to the data in order to compare the rate of growth in the two cohorts.
RESULTS: Neither cases nor controls had significant growth failure. However, when the mean z-scores for weight and height were analysed, there was a difference between the two groups starting at fourth month of life. When the growth pattern in the first year was analysed longitudinally using mixed models, it emerged that children who develop CD had a significantly lower growth rate in weight z-score (-0.028/month; 95% CI -0.038 to -0.017; p<0.001) and in length/height z-score (-0.018/month; 95% CI -0.031 to -0.005; p=0.008) than those who do not develop CD. When the whole follow-up period was analysed (0-6 years), differences between groups in both weight and length/height z-scores were confirmed.
CONCLUSION: The growth of children at risk of CD rarely fell below 'clinical standards'. However, growth rate was significantly lower in cases than in controls. Our data suggest that peculiar pathways of growth are present in children who develop CD, long before any clinical or serological signs of the disease appear. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gastroenterology; growth; paediatric practice

Mesh:

Year:  2020        PMID: 32354718     DOI: 10.1136/archdischild-2019-317976

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  3 in total

1.  Gluten consumption and inflammation affect the development of celiac disease in at-risk children.

Authors:  Renata Auricchio; Ilaria Calabrese; Martina Galatola; Donatella Cielo; Fortunata Carbone; Marianna Mancuso; Giuseppe Matarese; Riccardo Troncone; Salvatore Auricchio; Luigi Greco
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.996

2.  Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes.

Authors:  Monia Porpora; Mariangela Conte; Giuliana Lania; Claudia Bellomo; Luciano Rapacciuolo; Fernando Gabriel Chirdo; Renata Auricchio; Riccardo Troncone; Salvatore Auricchio; Maria Vittoria Barone; Merlin Nanayakkara
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

Review 3.  Pivotal Role of Inflammation in Celiac Disease.

Authors:  Maria Vittoria Barone; Renata Auricchio; Merlin Nanayakkara; Luigi Greco; Riccardo Troncone; Salvatore Auricchio
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.